- Home
- LGND vs ASTH Comparison
LGND vs ASTH Comparison
Compare LGND & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- ASTH
- Stock Information
- Founded
- LGND 1987
- ASTH 1994
- Country
- LGND United States
- ASTH United States
- Employees
- LGND N/A
- ASTH N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- LGND Health Care
- ASTH Consumer Discretionary
- Exchange
- LGND Nasdaq
- ASTH Nasdaq
- Market Cap
- LGND 2.0B
- ASTH 1.7B
- IPO Year
- LGND 1992
- ASTH N/A
- Fundamental
- Price
- LGND $120.25
- ASTH $24.29
- Analyst Decision
- LGND Strong Buy
- ASTH Strong Buy
- Analyst Count
- LGND 8
- ASTH 8
- Target Price
- LGND $144.71
- ASTH $53.29
- AVG Volume (30 Days)
- LGND 139.7K
- ASTH 268.5K
- Earning Date
- LGND 08-05-2025
- ASTH 08-06-2025
- Dividend Yield
- LGND N/A
- ASTH N/A
- EPS Growth
- LGND N/A
- ASTH N/A
- EPS
- LGND N/A
- ASTH 0.73
- Revenue
- LGND $181,488,000.00
- ASTH $2,250,574,000.00
- Revenue This Year
- LGND $18.41
- ASTH $34.97
- Revenue Next Year
- LGND $18.87
- ASTH $21.52
- P/E Ratio
- LGND N/A
- ASTH $33.08
- Revenue Growth
- LGND 53.40
- ASTH 54.81
- 52 Week Low
- LGND $81.74
- ASTH $23.12
- 52 Week High
- LGND $129.90
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- LGND 67.64
- ASTH 44.86
- Support Level
- LGND $111.72
- ASTH $24.13
- Resistance Level
- LGND $115.53
- ASTH $25.80
- Average True Range (ATR)
- LGND 3.19
- ASTH 1.15
- MACD
- LGND 0.04
- ASTH 0.07
- Stochastic Oscillator
- LGND 95.79
- ASTH 29.25
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.